Monday, August 8, 2022
Home Novavax leads the way for protein-based Covid vaccines Novavax leads the way for protein-based Covid vaccines

Novavax leads the way for protein-based Covid vaccines

covid, COVID-19, Covovax, GSK,Matrix-M, Nikolai Petrovsky, Novavax, Nuvaxovid, Peter Hotez, protein-based, Sanofi, Serum, Vaccine, WHO

Vaccines that do not use genetic material but instead use proteins or small pieces of protein from the Covid virus Spike cover, bound to a well-trusted cold virus vector are arriving – and they have new clinical data plus a safer and more effective history behind them.